The relationship between blood pressure variability and catecholamine metabolites: a pilot study

Area of Science:

• Cardiology
• Nephrology
• Clinical Biochemistry

Background:

• Ambulatory blood pressure variability (ABPV) is a significant predictor of cardiovascular risk in hypertensive individuals.
• The specific factors contributing to ABPV remain incompletely understood, necessitating further investigation for effective hypertension management.

Purpose of the Study:

• To explore the relationship between ABPV and urinary catecholamine metabolites.
• To provide a rationale for targeted therapeutic interventions in hypertension management.

Main Methods:

• A pilot study involving 20 primary hypertension patients (14 female, aged 23-71).
• 24-hour ambulatory blood pressure monitoring (Del Mar Reynolds).
• 24-hour urine collection analyzed for metadrenaline and normetadrenaline using reverse-phase chromatography and electrochemical detection.

Main Results:

• A significant positive correlation was found between urinary normetadrenaline concentration and systolic blood pressure (SBP) variability (r=0.493, P=0.02).
• Normetadrenaline concentration also correlated with the SBP coefficient of variability (r=0.490, P=0.02).
• No significant correlation was observed between metadrenaline concentration and SBP variability or its coefficient of variability.

Conclusions:

• Urinary normetadrenaline levels are associated with SBP variability in hypertensive patients.
• The findings suggest a potential role for sympathetic nervous system activity in influencing SBP variability.
• Further research is warranted to elucidate the mechanisms linking catecholamines and blood pressure variability in hypertension.